$1.36
+0.06 (+4.62%)
Open$1.28
Previous Close$1.30
Day High$1.36
Day Low$1.27
52W High$36.00
52W Low$1.00
Volume—
Avg Volume102.2K
Market Cap9.29M
P/E Ratio—
EPS$-1.34
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,599.3% upside
Current
$1.36
$1.36
Target
$36.71
$36.71
$29.06
$36.71 avg
$43.55
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.85M | 1.83M | 1.75M |
| Net Income | 558.6K | 478.0K | 437.1K |
| Profit Margin | 30.2% | 26.2% | 25.0% |
| EBITDA | 671.1K | 736.1K | 607.5K |
| Free Cash Flow | 473.4K | 406.9K | 399.5K |
| Rev Growth | +1.8% | +20.8% | +4.5% |
| Debt/Equity | 0.11 | 0.11 | 0.14 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,403.15 | +3.63% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $281.29 | +1.84% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $147.81 | +0.74% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.47 | +0.27% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $82.35 | +3.72% | 12.8 | 33.59B |